What clinical trials are available for recurrent Pancreatic Cancer

Clinical Trials for Recurrent Pancreatic Cancer

I appreciate this important question. Finding the right clinical trial can be a meaningful option when pancreatic cancer returns. Let me explain what's available and how to approach this.

Why Clinical Trials Matter for Recurrent Pancreatic Cancer

According to the NCCN Guidelines for Patients: Pancreatic Cancer, clinical trials are particularly important for pancreatic cancer because most standard treatments aren't effective long-term. When cancer recurs, your medical team should actively discuss trial options with you—this is now part of standard care recommendations.

As Dr. [removed] Strickler from Duke University emphasizes in recent pancreatic cancer education: "For a disease like pancreas cancer, which is so rarely cured with surgery alone, or with chemotherapy and surgery alone, it's important to know that this future [of precision medicine and clinical trials] is probably going to be the way that we can really move the needle on a disease that's largely been considered to be incurable."

Current Trial Approaches for Advanced/Recurrent Disease

Several categories of clinical trials are actively recruiting patients with recurrent pancreatic cancer:

1. Immunotherapy Combinations

• Trials combining immunotherapy with chemotherapy (like mFOLFIRINOX) are recruiting patients with advanced disease, including those who have relapsed after prior treatment
• These trials test whether adding immune-boosting drugs to standard chemotherapy improves outcomes

2. Targeted Therapy Trials

• KRAS-targeted therapies: KRAS mutations drive about 87% of pancreatic cancers. New drugs targeting KRAS are showing promise in clinical trials with minimal side effects
• Other genetic targets: If your tumor has specific mutations (BRCA, PALB2, MSI-high, etc.), targeted drugs may be available

3. Emerging Approaches

• Cancer vaccine trials (personalized neoepitope vaccines)
• Electricity-based treatments (like the PANOVA-4 trial, with data anticipated in 2026)
• Novel drug combinations being tested in Phase II/III trials

How to Find Trials Specific to Your Situation

The NCCN Guidelines recommend asking your doctor these specific questions:

1. "Do you recommend that I consider a clinical trial for treatment?"
2. "How do I find clinical trials in which I can participate?"
3. "What are the treatments used in the clinical trial?"
4. "What are the risks and benefits of this treatment?"
5. "What side effects should I expect and how will they be managed?"
6. "How will you know if the treatment is working?"

Key Resources to Search

• ClinicalTrials.gov - The National Institutes of Health database with comprehensive trial listings
• Let's Win Trial Finder - Pancreatic Cancer Action Network's specialized database for pancreatic cancer trials
• Your oncologist - Ask specifically about trials at academic medical centers, which often have access to cutting-edge research

Important Considerations

Dr. [removed] emphasizes that molecular profiling of your tumor is critical. Before searching for trials, make sure your oncologist has:

• Performed genetic testing on your tumor tissue
• Tested for microsatellite instability (MSI)
• Identified any specific mutations that might make you eligible for targeted therapy trials

Carry a copy of your molecular profiling report with you—it often doesn't automatically transfer between healthcare systems and is essential when discussing trial eligibility.

A Word About Recurrent Disease

If you've had prior treatment and relapsed, you may still be eligible for trials on a case-by-case basis. According to the guidelines, your medical team should evaluate whether you're a candidate based on:

• Your overall health status
• What treatments you've already received
• Your tumor's genetic profile
• Your performance status (ability to tolerate treatment)

---

Questions to Ask Your Oncology Team Right Now

1. Has my tumor been molecularly profiled? Can I get a copy of that report?
2. Are there clinical trials you recommend for my specific mutation profile?
3. Should I consider a second opinion at an academic medical center that specializes in pancreatic cancer?
4. What are the eligibility requirements for trials you're recommending?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.